Sarilumab and tocilizumab are equally effective in reducing organ support duration and death in patients who are critically ill with COVID-19.

Koenig's experience with Scott 24-Hour Sanitizing Wipes, he said, reflects a broader truth about innovation at large ...

Objective This study aimed to assess the coronavirus disease 2019 (COVID-19) hospitalisation costs and its associated factors on Nepalese households during the second wave of the pandemic, within the ...

UK remote and hybrid work ONS overview More than a quarter (28%) of working adults in Great Britain hybrid worked between January and March 2025 The ...

New research finds that nearly half of the racial and ethnic disparities in outpatient COVID-19 antiviral prescriptions stem ...